SHL informed by Prime Finance Corporation and Copper Valley Finance Ltd that they have purchased 1,431,607 shares of SHL.

SHL  informed by Prime  Finance  Corporation  (a  company  affiliated  with  Mr.  Eyal Ofer) and Copper Valley Finance Ltd (a company affiliated with Prof. Shlomo Ben Haim) that they have purchased 1,431,607 shares of SHL.
Tel Aviv/Zurich, 22  May 2012  –  SHL Telemedicine Ltd. (SIX  Swiss Exchange: SHLTN),
a leading provider and developer of advanced personal telemedicine  solutions  is
pleased to announce that  it  has been informed by Prime Finance Corporation (a
company affiliated with Mr. Eyal Ofer) and Copper Valley Finance Ltd (a company
affiliated with Prof. Shlomo Ben Haim) that they have purchased 1,431,607 shares of
SHL.
Prime Finance Corporation has purchased 715,804 shares, which account for 6.90% of
SHL’s issued share capital (excluding  treasury shares held by SHL) and Copper Valley
Finance Ltd has purchased 715,803 shares, which account for 6.90% of SHL’s issued
share capital (excluding treasury shares held by SHL).
SHL indicates that before the aforementioned purchases, and during the first quarter of
2012, a subsidiary of SHL has signed a Joint Venture Agreement with companies which
are affiliated with Mr. Eyal Ofer and Prof. Shlomo Ben Haim, in order to found a joint
venture entity, which will explore the feasibility of SHL’s activity in the Japanese market.

About SHL Telemedicine
SHL  Telemedicine  Ltd. specializes  in  developing  and  marketing  advanced  personal
telemedicine  systems  as  well  as providing  comprehensive  telemedicine  solutions
including  medical  call  centers  to  individuals  and  to  the  healthcare  community. As  a
leading provider of remote health services in cardiology and in other medical areas, SHL
maintains business operations in Europe, mainly in Germany, and at its home market in
Israel.  In  the  US,  certain  SHL  telemedicine  products  are  distributed  by  Philips
Healthcare. SHL  is  listed  on  the  SIX  Swiss  Exchange  (SHLTN, ISIN:  IL0010855885,
Security No.: 1128957). More information available at: www.shl-telemedicine.com. 

For further information please contact:

  • Erez Alroy, Co-CEO, Phone: +972 3561 22 12, ereza@shl-telemedicine.com
  • Martin Meier-Pfister, IRF Communications, Phone: +41 43 244 81 40, shl@irfcom.ch
Some  of  the  information  contained  in  this  press  release  contains  forward-looking  statements.
Readers  are  cautioned  that  any  such  forward-looking  statements  are  not  guarantees  of  future
performance and involve risks and uncertainties, and that actual results may differ materially from
those  in  the  forward-looking  statements  as  a  result  of  various  factors.  SHL  Telemedicine
undertakes no obligation to publicly update or revise any forward-looking statements.